{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:24:27Z","timestamp":1790688267322,"version":"4.1.0"},"reference-count":20,"publisher":"BMJ","issue":"6","funder":[{"name":"Institut National de la Sant et de la Recherche Mdicale"},{"name":"Universit Pierre et Marie Curie"},{"name":"Socit Francophone du Diabte"},{"name":"AFERO"},{"DOI":"10.13039\/501100020699","name":"Institute of Cardiometabolism and Nutrition","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020699","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2017,3,27]]},"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Type-2 familial partial lipodystrophy (FPLD2) is a rare autosomal dominant lipodystrophic disorder due to mutations in <jats:italic>LMNA<\/jats:italic> encoding lamin A\/C, a key epigenetic regulator. FPLD2 severity is determined by the occurrence of metabolic complications, especially diabetes and hypertriglyceridaemia. We evaluated the disease history and severity over generations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective study of the largest cohort of patients with FPLD2 reported to date investigates 85 patients from 24 families comprising three generations (G1: n=39; G2: n=41; G3: n=5).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Lipodystrophy appears with the same characteristics and at the same age in first generation (G1;18.6\u00b11.5 years) and second generation (G2;15.9\u00b10.8 years). Despite similar body mass index (23.7\u00b10.6 vs 23.8\u00b10.6\u2009kg\/m<jats:sup>2<\/jats:sup>), the mean delay between the onset of lipodystrophy and diabetes was far shorter in G2 (10.5\u00b12.4 years) than in G1 (29.0\u00b13.5 years) (p=0.0002). The same is true for the delay preceding hypertriglyceridaemia (G2: 4.5\u00b11.4; G1: 19.3\u00b13.2 years) (p=0.002), revealing an anticipation phenomenon. Observations in G3, and analysis within each family of disease history and diagnostic procedures, confirmed this result.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study is a rare example of anticipation unrelated to a trinucleotide expansion. Discovery of this early occurrence of metabolic complications in young generations underlines the utility of presymptomatic genetic diagnosis, with careful metabolic screening and preventive lifestyle in all at-risk individuals.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmedgenet-2016-104437","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T20:55:21Z","timestamp":1492116921000},"page":"413-416","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["<i>LMNA<\/i>-associated partial lipodystrophy: anticipation of metabolic complications"],"prefix":"10.1136","volume":"54","author":[{"given":"Isabelle","family":"Jeru","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Genetics, Saint-Antoine Hospital, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"},{"name":"Inserm UMR_S938, Saint-Antoine Research Center, Institute of Cardiometabolism and Nutrition, Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vatier","sequence":"additional","affiliation":[{"name":"Inserm UMR_S938, Saint-Antoine Research Center, Institute of Cardiometabolism and Nutrition, Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France"},{"name":"Department of Endocrinology, Diabetes and Reproductive Endocrinology, AP-HP, Saint-Antoine Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Inserm U1190, Lille University Hospital, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lascols","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Saint-Antoine Hospital, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"},{"name":"Inserm UMR_S938, Saint-Antoine Research Center, Institute of Cardiometabolism and Nutrition, Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Saint-Antoine Hospital, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"},{"name":"Inserm UMR_S938, Saint-Antoine Research Center, Institute of Cardiometabolism and Nutrition, Sorbonne Universit\u00e9s, UPMC Univ Paris 6, Paris, France"},{"name":"Department of Endocrinology, Diabetes and Reproductive Endocrinology, AP-HP, Saint-Antoine Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"2025101721560796000_54.6.413.1","doi-asserted-by":"publisher","DOI":"10.1038\/72807"},{"key":"2025101721560796000_54.6.413.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2013.12.015"},{"key":"2025101721560796000_54.6.413.3","doi-asserted-by":"publisher","DOI":"10.1021\/bi020704g"},{"key":"2025101721560796000_54.6.413.4","doi-asserted-by":"publisher","DOI":"10.1101\/gr.159400.113"},{"key":"2025101721560796000_54.6.413.5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad4991"},{"key":"2025101721560796000_54.6.413.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2008.02.018"},{"key":"2025101721560796000_54.6.413.7","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu728"},{"key":"2025101721560796000_54.6.413.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-011-1022-9"},{"key":"2025101721560796000_54.6.413.9","first-page":"973","article-title":"Anticipation: an old idea in new genes","volume":"59","author":"McInnis","year":"1996","journal-title":"Am J Hum Genet"},{"key":"2025101721560796000_54.6.413.10","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1212\/WNL.53.6.1328","article-title":"Preliminary evidence for anticipation in genetic E200K Creutzfeldt-Jakob disease","volume":"53","author":"Rosenmann","year":"1999","journal-title":"Neurology"},{"key":"2025101721560796000_54.6.413.11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/WNL.55.3.451-a","article-title":"Anticipation in early- but not late-onset familial amyloid polyneuropathy (TTR met 30) in Japan","volume":"55","author":"Misu","year":"2000","journal-title":"Neurology"},{"key":"2025101721560796000_54.6.413.12","doi-asserted-by":"publisher","DOI":"10.1007\/s100380200055"},{"key":"2025101721560796000_54.6.413.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.6.819"},{"key":"2025101721560796000_54.6.413.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0693-1"},{"key":"2025101721560796000_54.6.413.15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2337\/diacare.24.4.646","article-title":"Factors predicting the age when type 2 diabetes is diagnosed in Hong Kong Chinese subjects","volume":"24","author":"Lee","year":"2001","journal-title":"Diabetes Care"},{"key":"2025101721560796000_54.6.413.16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/dmrr.758","article-title":"The age at diagnosis of type 1 diabetes continues to decrease in Belgian boys but not in girls: a 15-year survey","volume":"23","author":"Weets","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"2025101721560796000_54.6.413.17","first-page":"CR262","article-title":"Preliminary evidence of genetic anticipation in type 2 diabetes mellitus","volume":"11","author":"Yaturu","year":"2005","journal-title":"Med Sci Monit"},{"key":"2025101721560796000_54.6.413.18","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.7326\/0003-4819-36-5-1285","article-title":"An analysis of the phenomenon of \"anticipation\" in diabetes mellitus","volume":"36","author":"Steinberg","year":"1952","journal-title":"Ann Intern Med"},{"key":"2025101721560796000_54.6.413.19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrendo.2016.87","article-title":"The role of diet and exercise in the transgenerational epigenetic landscape of T2DM","volume":"12","author":"Barr\u00e8s","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"2025101721560796000_54.6.413.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1321195111"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2016-104437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:56:14Z","timestamp":1760763374000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2016-104437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,5,26]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.1136\/jmedgenet-2016-104437"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2016-104437","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}